Systemic sclerosis is a complex disease characterized by extensive fibrosis, microvascular alterations, and additional sequelae. Microvascular alterations can cause painful ulcers and necrosis; however, conservative or surgical treatment is often challenging in terms of healing. The study aimed to describe a toe ulcer with systemic sclerosis and its’ successful treatment with spinal cord stimulation. An 83-year-old woman, who was diagnosed with systemic sclerosis over the past decade, was distressed by a non-healing toe ulcer for an extended period of time. The patient underwent spinal cord stimulation treatment with the expectation of pain relief and an improvement in microcirculatory insufficiency. Her pain scales and microcirculation improved, and the toe ulcer healed. Furthermore, the frequency of Raynaud’s symptoms was reduced, and the patient’s pain decreased. There was no recurrence of the ulcer and she no longer needed a cane for walking.
Abstract/References
Spinal cord stimulation for the treatment of pain and toe ulceration associated with systemic sclerosis: a case report
Hiroyuki Ito, Takafumi Tanei, Kyoko Sugawara, Yu Sando, Naohiro Hori
-
Hiroyuki Ito
Department of Plastic and Reconstructive Surgery, Komaki City Hospital
-
Takafumi Tanei
Department of Neurosurgery, Komaki City Hospital
-
Kyoko Sugawara
Department of Dermatology, Komaki City Hospital
-
Yu Sando
Department of Dermatology, Komaki City Hospital
-
Naohiro Hori
Department of Plastic and Reconstructive Surgery, Komaki City Hospital
Abstract
References
1. Gabrielli A, Avvediment.o EV, Krieg T. Systemic sclerosis. N Engl J Med, 360:1989-2003, 2009.
2. Barsotti S, Orlandi M, Codullo V, et al. One year in review 2019:systemic sclerosis. Clin Exp Rheumatol, 119:3-14, 2019.
3. The British Pain Society (2009). Spinal cord stimulation for the management of pain: recommendations for best clinical the management of pain: recommendations for best clinical practice. Available at:https://www.britishpainsociety.org/static/uploads/resources/files/book_scs_main_1.pdf, Accessed November 5, 2020.
4. Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain, 144:35-42, 2009.
5. Cano A, Leonard MT, Franz A. The significant other version of the Pain Catastrophizing Scale (PCS-S):preliminary validation. Pain, 119:26-37, 2005.
8. Jivegard LE, Augustinsson LE, Holm J, Risberg B, Ortenwall P. Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia:a prospective randomised controlled study. Eur J Vasc Endovasc Surg, 9:421-425, 1995.
9. Spincemaille GH, Klomp HM, Steyerberg EW, Habbema JD. Pain and quality of life in patients with critical limb ischaemia:results of a randomized controlled multicentre study on the effect of spinal cord stimulation. ESES study group. Eur J Pain, 4:173-184, 2000.
10. Claeys LG, Horsch S. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. Int Angiol, 15:344-349, 1996.
11. Kumar K, Toth C, Nath RK, Verma AK, Burgess JJ. Improvement of limb circulation in peripheral vascular disease using epidural spinal cord stimulation: a prospective study. J Neurosurg, 86:662-669, 1997.
12. Fiume D. Spinal cord stimulation in peripheral vascular pain. Appl Neurophysiol, 46:290-294, 1983.
14. Neuhauser B, Perkmann R, Klingler PJ, Giacomuzzi S, Kofler A, Fraedrich G. Clinical and objective data on spinal cord stimulation for the treatment of severe Raynaud’s phenomenon. Am Surg, 67:1096-1097, 2001.
15. Sibell DM, Colantonio AJ, Stacey BR. Successful use of spinal cord stimulation in the treatment of severe Raynaud’s disease of the hands. Anesthesiology, 102:225-227, 2005.
Figures (4)
